Search This Blog

Monday, May 4, 2020

Omega Healthcare withdraws guidance as COVID-19 affects operators

Not surprisingly, Omega Healthcare Investors (NYSE:OHI) withdraws its 2020 guidance issued in February as it didn’t contemplate adverse effects from the COVID-19 pandemic.
OHI’s operators are facing a “challenging period on all fronts… they have seen declining occupancy and significantly elevated costs combine to materially impact their financial performance,” said Omega CEO Taylor Pickett.
He adds that federal and state agencies overseeing skilled nursing have “acted quickly and effectively to provide financial support to the industry.”
Q1 adjusted FFO per share of 79 cents beats the consensus estimate of 78 cents.
Q1 revenue $253.0M exceeds the $218.0M consensus estimate and increased from $223.7M a year ago.
Q1 total operating expenses of $107.1M compares with $101.5M a year ago.
Conference call on May 5 at 10:00 AM ET.
https://seekingalpha.com/news/3568731-omega-healthcare-withdraws-guidance-covidminus-19-affects-operators

Corcept Therapeutics EPS beats by $0.13, beats on revenue

Corcept Therapeutics (NASDAQ:CORT): Q1 Non-GAAP EPS of $0.34 beats by $0.13; GAAP EPS of $0.25 beats by $0.03.
Revenue of $93.2M (+43.8% Y/Y) beats by $6.19M.
https://seekingalpha.com/news/3568623-corcept-therapeutics-eps-beats-0_13-beats-on-revenue

Acadia Healthcare EPS beats by $0.04, misses on revenue

Acadia Healthcare (NASDAQ:ACHC): Q1 Non-GAAP EPS of $0.42 beats by $0.04; GAAP EPS of $0.38 misses by $0.01.
Revenue of $782.8M (+2.9% Y/Y) misses by $9.75M.
https://seekingalpha.com/news/3568633-acadia-healthcare-eps-beats-0_04-misses-on-revenue

GenMark Diagnostics EPS beats by $0.02, beats on revenue

GenMark Diagnostics (NASDAQ:GNMK): Q1 GAAP EPS of -$0.12 beats by $0.02.
Revenue of $38.74M (+79.9% Y/Y) beats by $3.94M.
Shares +12.78%.
https://seekingalpha.com/news/3568643-genmark-diagnostics-eps-beats-0_02-beats-on-revenue

Addus HomeCare EPS beats by $0.18, beats on revenue

Addus HomeCare (NASDAQ:ADUS): Q1 Non-GAAP EPS of $0.77 beats by $0.18; GAAP EPS of $0.54 in-line.
Revenue of $190.2M (+36.6% Y/Y) beats by $10.98M.
https://seekingalpha.com/news/3568657-addus-homecare-eps-beats-0_18-beats-on-revenue

Tenet Healthcare EPS beats by $0.96, misses on revenue

Tenet Healthcare (NYSE:THC): Q1 Non-GAAP EPS of $1.28 beats by $0.96; GAAP EPS of $0.89 beats by $1.04.
Revenue of $4.52B (-0.7% Y/Y) misses by $110M.
https://seekingalpha.com/news/3568678-tenet-healthcare-eps-beats-0_96-misses-on-revenue

Varian Medical Systems EPS in-line, beats on revenue

Varian Medical Systems (NYSE:VAR): Q2 Non-GAAP EPS of $0.85 in-line; GAAP EPS of $0.47 misses by $0.29.
Revenue of $794.5M (+1.9% Y/Y) beats by $24.51M.
https://seekingalpha.com/news/3568685-varian-medical-systems-eps-in-line-beats-on-revenue